Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Infigen

Infigen is a biotechnology company developing nuclear transfer and genomic technologies for applications in human healthcare. We focus on four distinct yet related platforms:Therapeutic Proteins
Transgenic animals as bioreactors to produce proteins used in a variety of therapeutic applications including surgery, trauma, cancer therapy, urinary and fecal incontinence, cosmetic reconstruction and chronic diseases.
Non-transgenic, cloned animals to replicate unique immune responses used in human diagnostics.
Xenotransplantation
Genetically modified miniature pigs as an alternative source of organs, tissues, and cells for human transplant.
Genomic Reprogramming
Mouse, cattle, and porcine embryos as a tool to investigate and assess reprogramming for the purpose of discovery and developing novel therapies and medicines.
Animal Models of Disease
Genetically modified pigs to study human disease etiology and to test new therapies before use in humans. Both classical and unique, proprietary technologies to target genes for change are employed.


Contact Details:
1825 Infinity Drive
DeForest
Wisconsin
53532
United States of America
Tel:(608) 846-0500
Fax:(608) 846-0520
Email:info@infigen.com
WWW:

www.infigen.com/




Loading...

Recent Publications by Infigen:

Nucleoplasmin facilitates reprogramming and in vivo development of bovine nuclear transfer embryos.
Successful cloning by somatic cell nuclear transfer (NT) involves an...
31st March, 2007
Infigen, Inc., Madison, Wisconsin 53718, USA. Mol Reprod Dev. 2006 Aug;73(8):977-86.
DOI Direct Link
Direct and rapid modification of a porcine xenoantigen gene (GGTA1).
The ability to modify animal genomes rapidly at a specific locus would be...
9th December, 2006
Infigen, Deforest, WI, USA. Transplantation. 2006 Oct 15;82(7):975-8.
DOI Direct Link
Commercial applications of nuclear transfer cloning: three examples.
Potential applications of cloning go well beyond the popularly envisioned...
6th April, 2006
Infigen Inc., 1825 Infinity Drive, DeForest, WI 53532, USA. Reprod Fertil Dev. 2005;17(1-2):59-68.
Identification of differentially expressed genes in individual bovine preimplantation embryos produced by nuclear transfer: improper reprogramming of genes required for development.
Using an interwoven-loop experimental design in conjunction with highly...
2nd September, 2005
Infigen, Inc., DeForest, Wisconsin 53532, USA. Biol Reprod. 2005 Mar;72(3):546-55. Epub 2004 Oct 13.
DOI Direct Link
Genome-wide epigenetic alterations in cloned bovine fetuses.
To gain a better understanding of global methylation differences...
22nd October, 2003
Infigen, Inc., DeForest, Wisconsin 53532, USA. Biol Reprod. 2003 Mar;68(3):1009-14.

View more Infigen research publications.

Infigen Patents:

US Patent No.Title
6700037 Method of cloning porcine animals
6680199 In vitro activation of mammalian oocytes
6603059 Method of cloning animals
6395958 Method of producing a polypeptide in an ungulate
6258998 Method of cloning porcine animals

View more Infigen patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1309 times since April 2007, the link to the organisation's website has been followed 273 times

Recent Search Terms used to find this page: infigen | Infigen Inc | Infigen Inc | Infigen Inc De Forest | Infigen Inc. | Infigen | infingen inc | infigen | Infigen, Inc., Madison, Wisconsin 53718, USA. | Infigen Inc. Madison Wisconsin 53718 USA. | .

Search for more companies in DeForest

Search for more companies in Wisconsin



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Infigen

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.